Compound Kushen Injection + 5-Fluorouracil

1p36−, intact P53, and amplified MYCN (CHP-212)
1p36−, P53 null mutation, and amplified MYCN (LAN-1)
1p36−, mutated P53, and normal MYCN status (SK-N-AS)
AR-V7 overexpressing prostate cancer cell lines
EnZr overexpressing prostate cancer cell line

DAC (20 mg/m2/day i.v.) for 5 days every 28 days for at least 3 cycles
BIX vs DMSO - Controlling for SMYD2 mutation status
Rapamycin vs DMSO - Controlling for SMYD2 mutation status
Multiple cell lines - JQ1 vs DMSO controlling for cell line
AICAR vs DMSO - Controlling for mutation differences
Chloramphenicol vs DMSO - Controlling for mutation differences
Fibroblast patient cell lines carrying mutations in complex I genes NDUFS2 and ND5; OXPHOS deficiency
Resveratrol vs DMSO - Controlling for mutation differences
Long term culture (90 days) in CP1203; BETi resistant clone vs DMSO in resistant clone
Long term culture (9 mo) in CP1203; BETi resistant clone vs DMSO in resistant clone
JQ1 vs DMSO - Controlling for cell line differences
doxycycline-inducible shRNA system to reduce BRD4
BRD4 Knockdown vs Non-targetting control - controlling for cell line differences
Dox vs Control - Controlling for cell line and mutation differences
DAC vs Control - Controlling for cell line differences
Dox vs Control - Controlling for cell line differences
Etoposide vs Control - Controlling for cell lines differences
MMS vs Control - Conntrolling for cell lines differences
Paclitaxel vs Control - Controlling for cell line differences
Cyclocreatine vs Control - Controlling for cell line differences
Etoposide vs Control - Controlling for cell line differences
4Gy IR vs Control - Controlling for cell line differences
acquired BCR-ABL independent resistance following culture in ponatinib.
incubated with two dosages of FB23-2, and the known histone demethylase inhibitors JIB-04
TNFa + transfection with siRNA and GapmeR
CC-122 is a direct descendent of thalidomide and lenalidomide
THZ1 vs Control - Controlling for cell line
siRNA targeting of E2 reversed repression of E2 targed genes
Concentrations (0.3uM, 1uM, 3uM) for 6 and 24 hrs
Decitabine 100 nM vs DMSO - Controlling for cell line differences
Decitabine 300 nM vs DMSO - Controlling for cell line differences
Decitabine vs DMSO - Controlling for cell line differences and DAC conc.
ABBV-075 vs DMSO - Controlling for cell line differences
ABBV-744 vs DMSO - Controlling for cell line differences
Decitabine vs DMSO - Controlling for cell line differences; (A549, H1299, CL1-0, CL1-5, H1792, PC9); Only one replicate per cell line
Sequential treatment (azacitidine for day 1 to day 4 and BAY1436032 for day 5 to day 9)
Simultaneous treatment (azacitidine for day 1 to day 4 and BAY1436032 for day 1 to day 5)
CD45+ Cells isolated from AML xenografts; TRC105 (anti-human CD105 antibody)
Mitomycin C vs No Treatment - Controlling for cell line differences
Decitabine vs DMSO - Controlling for cell line differences; No publication and limited metadata
Two and half (2.5) liters of boiling water were added to 100 g crushed leaf material and the mixture was stirred for 16 h at room temperature
Non-Hodgkin's lymphoma cell line; No publication and limited metadata
Azacitidine vs Untreated 125nM - Controlling for cell line differences
Azacitidine vs Untreated 250nM - Controlling for cell line differences
Azacitidine vs Untreated 500nM - Controlling for cell line differences
Decitabine vs Untreated 12.5nM - Controlling for cell line differences
Decitabine vs Untreated 25nM - Controlling for cell line differences
Decitabine vs Untreated 5nM - Controlling for cell line differences
Azacitidine vs untreated in HH cells - Controlling for concentration differences
Decitabine vs untreated in HH cells - Controlling for concentration differences
Decitabine vs untreated in PF382 cells - Controlling for concentration differences
Azacitidine vs untreated in PF382 cells - Controlling for concentration differences
Azacitidine vs untreated in TLOm1 cells - Controlling for concentration differences
Decitabine vs untreated in TLOm1 cells - Controlling for concentration differences
Manuscript states different concentration than sample metadata. Use manuscript concentration
TMZ-resistant cell line vs non-resistant